NEXT GENERATION INVESTMENT BANKING

Members network
Limited Mobile Version
Follow this company and never miss a research update
DEX

DexTech Medical

Market Cap 410.1M

Redeye Research

Today
Day High
27.90
27.8
Day Low
26.70
Day Open
26.70
Prev Close
27.80
VWAP
N/A
Volume
0K
Turnover
0.007M
Top Broker
AVA
VWAP
26.4
Avg Volume
0K
Avg Turnover
0.012M
Top Brokers
AVA/SWB
VWAP
25.0
Avg Volume
1K
Avg Turnover
0.023M
Top Brokers
AVA/NON
VWAP
26.0
Avg Volume
1K
Avg Turnover
0.023M
Top Brokers
AVA/NON
52 week summary
Price Range
20.0
Last
40.0
Beta
N/A
Market Cap
410.1M
Total Return
-9.9%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
14.8M
Next Earnings Date
31 Aug
Stock Exchange
Aktietorget
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 15.4%
Change 12 Months -23.4%
Volume Trend
Average Volume 10 vs 60 Days -69.3%
Price VS
52 Week High -30.5%
50 Day Moving Average 10.3%
200 Day moving Average 11.5%

Add article markers

Compare DexTech Medical to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Anders R Holmberg, CEO
  • Executive board
  • Svante Wadman, Chairman of the board
Source: Millistream
Major Owners Equity Votes
Trois W Aktiebolag 17.1%
17.1%
Anders Holmberg 10.6%
10.6%
Sten Nilsson 9.7%
9.7%
Svante Wadman 9.5%
9.5%
Donald Ericsson Fastigheter Vi AB 7.6%
7.6%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
+ 0
0 Sales
- 0
Last 24 weeks
0 Purchases
+ 0
0 Sales
- 0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.


Community Posts

Be the first to write something about this company in the community.

Create new post